483 Document: Alnylam Pharmaceuticals Inc., May 4, 2018

FDANews 483 Alnylam Pharmaceuticals Inc. May 4 2018 top
Sean R. Marcsisin FDA Investigator Christina A. Capacci-Daniel FDA Investigator

On May 04, 2018, the FDA inspected Alnylam Pharmaceuticals Inc.'s Cambridge site. Explore the inspectional observations.